Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Slovin, S. F.; Beer, T. M.; Higano, C. S.; Tejwani, S.; Hamid, O.; Picus, J.; Harzstark, A.; Scher, H. I.; Lan, Z.; Lowy, I.
Abstract Title:	Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title:	45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	27
Issue:	15 Suppl.
Meeting Dates:	2009 May 29-Jun 2
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2009-05-20
Start Page:	268s
Language:	English
ACCESSION:	WOS:000276606604011
PROVIDER:	wos
DOI:	10.1200/jco.2012.30.15_suppl.513
Notes:	Meeting Abstract: 5138 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129730